Neonatal Clinical Trials

179 recruitingLast updated: June 18, 2026

There are 179 actively recruiting neonatal clinical trials across 59 countries. Studies span Not Applicable, Phase 3, Phase 2, Phase 4, Phase 1, Early Phase 1. Top locations include Boston, Massachusetts, United States, Philadelphia, Pennsylvania, United States, San Diego, California, United States. Updated daily from ClinicalTrials.gov.


Neonatal Trials at a Glance

179 actively recruiting trials for neonatal are listed on ClinicalTrialsFinder across 6 cities in 59 countries. The largest study group is Not Applicable with 59 trials, with the heaviest enrollment activity in Boston, Philadelphia, and San Diego. Lead sponsors running neonatal studies include Medical University of Graz, Boston Children's Hospital, and University of California, San Diego.

Treatments under study

About Neonatal Clinical Trials

Looking for clinical trials for Neonatal? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neonatal trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neonatal clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 179 trials

Recruiting
Phase 2

A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

Neonatal EncephalopathyNeonatal SeizureSeizure Newborn+1 more
University of California, San Diego133 enrolled5 locationsNCT05610085
Recruiting
Not Applicable

Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates

Neonatal resuscitationApnea Neonatal
Michelle Baczynski780 enrolled10 locationsNCT06849596
Recruiting

Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection

Sensorineural Hearing LossViral InfectionCytomegalovirus Infections+2 more
Rigshospitalet, Denmark630 enrolled2 locationsNCT07635368
Recruiting
Phase 3

A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Thrombocytopenia, Neonatal Alloimmune
Janssen Research & Development, LLC39 enrolled21 locationsNCT06449651
Recruiting
Phase 1

Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome

Staphylococcus AureusMicrobial ColonizationNeonatal Infection
Johns Hopkins University175 enrolled1 locationNCT06283355
Recruiting
Phase 3

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

Thrombocytopenia, Neonatal Alloimmune
Janssen Research & Development, LLC50 enrolled26 locationsNCT06533098
Recruiting
Not Applicable

ShotBlocker During Intramuscular Injection Randomized Control Trial

Neonatal Pain
Lauren Fortier200 enrolled1 locationNCT06624176
Recruiting

The UK 22 Week Study

Infant, Extremely PrematureIntensive Care, NeonatalExtreme Prematurity - Less Than 28 Weeks+1 more
Imperial College London100 enrolled1 locationNCT07616778
Recruiting

A Pilot Study for Systematic Neonatal Screening for Lysosomal Storage Diseases Using Tandem Mass Spectrometry

Neonatal ScreeningLysosomal Storage Diseases
University Hospital, Rouen100,000 enrolled2 locationsNCT04393701
Recruiting
Phase 3

Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)

Muscular Dystrophy, DuchenneDMDNeuromuscular Diseases (NMD)+10 more
Dyne Therapeutics90 enrolled1 locationNCT07608432
Recruiting
Not Applicable

Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure

Neonatal Brain Injuryperinatal morbidityMechanical Ventilation+10 more
Medical College of Wisconsin320 enrolled1 locationNCT07274527
Recruiting

Healthy Little Eyes

Neonatal EncephalopathyEncephalopathyHypoxic-ischemic encephalopathy.
University of Wisconsin, Madison125 enrolled1 locationNCT05971446
Recruiting

The Peripheral(-Muscle) Oxygenation and Perfusion Score as a New Non-invasive Tool to Predict Elevations in C-reactive Protein Levels in Neonates

Preterm neonatesInfectionNear-Infrared Spectroscopy+4 more
Medical University of Graz93 enrolled1 locationNCT07109856
Recruiting
Not Applicable

Neonate Cerebral Activity in Immediate Post Partum

Neonatal EncephalopathyAnoxia-Ischemia, Brain
Centre Hospitalier Universitaire, Amiens60 enrolled1 locationNCT04225975
Recruiting
Phase 4

Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes

Cerebral oxygen saturationInfant Respiratory Distress SyndromeCerebral Oxygenation+3 more
Medical University of Graz76 enrolled1 locationNCT07261787
Recruiting

Generating Intervals of Reference FFor Early Life Brain Biomarkers.

Biomarker in Early DiagnosisNeonatalReference Intervals
University College Cork150 enrolled1 locationNCT07585149
Recruiting
Not Applicable

NeoSHARK: Anatomical Versus Round Facemasks for Breathing Support in Preterm and Term Newborn Infants

Neonatal Intensive care
University College Dublin50 enrolled1 locationNCT07524517
Recruiting
Not Applicable

Against Chikungunya Virus and Neonatal Infection

TransfusionEncephalopathyNeonatal+1 more
Centre Hospitalier Universitaire de la Réunion60 enrolled2 locationsNCT07190560
Recruiting
Not Applicable

Effect of Thermoregulation Bundle Applied at Birth on Neonatal Physiological Parameters and Breastfeeding

Neonatal HypothermiaThermoregulationNeonatal Adaptation
Istanbul University - Cerrahpasa140 enrolled1 locationNCT07453264
Recruiting
Not Applicable

Feasibility of Aerodigestive Stimulation Therapy Trial

Feeding Disorder Neonatal
Sudarshan Jadcherla40 enrolled1 locationNCT06118697